Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
26.95
+0.67 (2.55%)
Sep 2, 2026, 4:00 PM EDT - Market closed
Braveheart Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $40 | Buy | Initiates | $40 | +48.42% | Aug 31, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 31, 2026 |
| Jefferies | Jefferies | Buy Initiates $48 | Buy | Initiates | $48 | +78.11% | Aug 31, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $45 | Buy | Initiates | $45 | +66.98% | Aug 31, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $48 | Buy | Initiates | $48 | +78.11% | Aug 31, 2026 |